The Mass Spectrometry and Proteomics Core will provide protein identification, phosphorylation site mapping, and develop strategies for relative quantification of proteins/phosphopeptides in order to aid in the understanding of the Tuberous sclerosis pathway and pathogenesis, LKB1/AMPK signaling and its role in Peutz-Jeghers syndrome, and a dissection of Tsc1/Tsc2/Tor/S6K signaling. Liquid chromatography coupled to tandem mass spectrometry (LC/MS/MS) will be used to identify proteins and phosphorylation sites as well as provide quantitative information for proteins and phosphorylation sites. Peptides from tryptic digestions will be analyzed by microcapillary reversed-phase LC/MS/MS using a LTQ linear ion trap mass spectrometer and a QSTAR Pulsar quadrupole-TOF mass spectrometer. Proteins and their phosphorylation sites will be identified after gel separation by interrogating non-redundant protein databases with peptide tandem mass spectra. Relative quantitation of proteins will be performed by isotopically labeling the proteins from different cell states with light and heavy amino acids, respectively, using stable isotope labeling of amino acids in cell culture (SILAC) using the QSTAR mass spectrometer or labeling post cell growth at the protein and/or peptide level using global internal standard technology (GIST) primary amine stable isotope labeling reagents. Ratios of light to heavy peptide pairs will be determined using both MSQuant and in-house developed software. Bioinformatics will be used for data management and data mining for biological significance.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Brigham and Women's Hospital
United States
Zip Code
Lewis Jr, Tommy L; Kwon, Seok-Kyu; Lee, Annie et al. (2018) MFF-dependent mitochondrial fission regulates presynaptic release and axon branching by limiting axonal mitochondria size. Nat Commun 9:5008
Eichner, Lillian J; Brun, Sonja N; Herzig, Sébastien et al. (2018) Genetic Analysis Reveals AMPK Is Required to Support Tumor Growth in Murine Kras-Dependent Lung Cancer Models. Cell Metab :
Deng, Jiehui; Wang, Eric S; Jenkins, Russell W et al. (2018) CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. Cancer Discov 8:216-233
Herzig, Sébastien; Shaw, Reuben J (2018) AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121-135
Du, Heng; Dreier, John R; Zarei, Mahsa et al. (2018) A novel mouse model of hemangiopericytoma due to loss of Tsc2. Hum Mol Genet 27:4169-4175
McBrayer, Samuel K; Mayers, Jared R; DiNatale, Gabriel J et al. (2018) Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma. Cell 175:101-116.e25
Kamareddine, Layla; Wong, Adam C N; Vanhove, Audrey S et al. (2018) Activation of Vibrio cholerae quorum sensing promotes survival of an arthropod host. Nat Microbiol 3:243-252
Wu, Shulin; Ye, Jianheng; Wang, Zongwei et al. (2018) Expression of aromatase in tumor related stroma is associated with human bladder cancer progression. Cancer Biol Ther 19:175-180
Ye, Jianheng; Zhang, Yanqiong; Cai, Zhiduan et al. (2018) Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer. BMC Urol 18:82
Cañadas, Israel; Thummalapalli, Rohit; Kim, Jong Wook et al. (2018) Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat Med 24:1143-1150

Showing the most recent 10 out of 289 publications